期刊文献+

去氢木香内酯抗肿瘤作用机制研究进展

Progress on Antitumor Mechanism of Dehydrocostus Lactone
下载PDF
导出
摘要 去氢木香内酯是从菊科云木香属植物木香Aucklandia lappa Decne.的根部提取的一种倍半萜内酯类化合物,是木香的主要活性成分之一,有抗菌、消炎、抗病毒、抗溃疡、抗糖尿病和抗肿瘤等药理活性。近年,去氢木香内酯在抗肿瘤领域引起了广泛关注。研究发现,去氢木香内酯能抑制肿瘤细胞的增殖和迁移能力,对肺癌、宫颈癌等癌症有抑制作用。其抗肿瘤机制主要包括抑制肿瘤细胞增殖、抑制肿瘤细胞侵袭和迁移、诱导肿瘤细胞凋亡和逆转肿瘤细胞多药耐药。本文对近年来去氢木香内酯的抗肿瘤作用机制进行了详细综述,旨在为该类药物在临床肿瘤治疗中提供新的理论支持、新的思路以及参考。 Dehydrocostus lactone is a sesquiterpene lactone compound extracted from the root of Aucklandia lappa Decne in Asteraceae family,and it is one of the main active components with pharmacological activities such antimicrobial,anti-inflammatory,antiviral,anti-ulcer,antidiabetic and antitumor actuities.In recent years,dehydrocostus lactone has attracted wide attention in the field of antitumor therapy.It is found that dehydrocostus lactone can inhibit the proliferation and migration ability of tumor cells,and has inhibitory effect on lung cancer,cervical cancer and other cancers.Its anti-tumor mechanism mainly includes inhibition of tumor cell proliferation,inhibition of tumor cell invasion and migration,induction of tumor cell apoptosis and reversal of tumor cell multidrug resistance.In this paper,the antitumor mechanism of dehydrocostus lactone is reviewed in detail in recent years,aiming to provide new theoretical support,new ideas and references for this class of drugs in clinical tumor therapy.
作者 杨超 陈强威 叶彬 YANG Chao;CHEN Qiang-wei;YE Bin(Guangzhou Baiyunshan Zhongyi Pharmaceutical Co.,Ltd.,Guangzhou 510530,China)
出处 《食品与药品》 CAS 2024年第3期I0005-I0009,共5页 Food and Drug
关键词 去氢木香内酯 抗肿瘤 作用机制 dehydrocostus lactone antitumor activity mechanism
  • 相关文献

参考文献12

二级参考文献165

  • 1文志云,陆国寿.清热解毒颗粒中绿原酸的含量测定[J].医学文选,2005,24(6):892-894. 被引量:7
  • 2赵东保,张卫,李明静,刘绣华.顶羽菊化学成分研究[J].中国中药杂志,2006,31(22):1869-1872. 被引量:26
  • 3王震凯,朱人敏.Wnt信号转导通路在肿瘤中的研究进展[J].医学研究生学报,2007,20(12):1294-1297. 被引量:29
  • 4Agoulnik, I.U., Hodgson, M.C., Bowden, W.A., Ittmann, M.M., 2011. INPP4B: the new kid on the PI3K block. Oncotarget 2, 321-328.
  • 5Akbani, R., Ng, EK.S., Werner, H.M.J., Shahmoradgofi, M., Zhang, F., Ju, Z., Liu, W., Yang, J.-Y., Yoshihara, K., Li, J., Ling, S., Seviour, E.G., Ram, ET., Minna, J.D., Diao, L., Tong, P., Heymach, J.V., Hill, S.M., Dondelinger, F., Stidler, N., Byers, L.A., Meric-Bernstam, F., Weinstein, J.N., Broom, B.M., Verhaak, R.G.W., Liang, H., Mukherjee, S., Lu, Y., Mills, G.B., 2014. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun. 5, 3887.
  • 6Alessi, D.R., James, S.R., Downes, C.E, Holmes, A.B., Gaffney, ER., Reese, C.B., Cohen, E, 1997. Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein ki- nase B . Curr. Biol. 7, 261-269.
  • 7Andjelkovic, M., Alessi, D.R., Meier, R., Fernandez, A., Lamb, N.J., Frech, M., Cron, E, Cohen, P., Lucocq, J.M., Hemmings, B.A., 1997. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515-31524.
  • 8Auger, K.R., Serunian, L.A., Soltoff, S.E, Libby, E, Cantley, L.C., 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57, 167-175.
  • 9Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya- Feldstein, J., Cordon-Cardo, C., Celeste Simon, M., Rafii, S., Pandolfi, RR, 2006. PML inhibits HIF-I translation and neoangiogenesis through repression of mTOR. Nature 442, 779-785.
  • 10Bhatt, J.R., Finelli, A., 2014. Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat. Rev. Urol. 11,517-525.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部